Journal of the American Chemical Society
Page 8 of 9
9) (a) Vineyard, B. D.; Knowles, W. S.; Sabacky, M. J.; Bachman,
Gembicky (UCSD) for assistance with X-Ray
crystallographic analysis. The authors are grateful to Dr.
Justine deGruyter for assistance with manuscript
revision.
G. L.; Weinkauff, D. J., Asymmetric hydrogenation. Rhodium
chiral bisphosphine catalyst. J. Am. Chem. Soc. 1977, 99, 5946–
5952. (b) Knowles, W. S., Asymmetric Hydrogenations (Nobel
Lecture 2001). Adv. Synth. Catal. 2003, 345, 3–13.
1
2
3
4
5
6
7
8
9
10) (a) Liu, D.; Zhang, X., Practical P-Chiral Phosphane Ligand
for Rh-Catalyzed Asymmetric Hydrogenation. Eur. J. Org.
Chem. 2005, 2005, 646–649. (b) Gao, W.; Lv, H.; Zhang, X.,
Rh/DuanPhos-Catalyzed Asymmetric Hydrogenation of β-
Acetylamino Vinylsulfides: An Approach to Chiral β-
Acetylamino Sulfides. Org. Lett. 2017, 19, 2877–2880.
11) Tang, W.; Qu, B.; Capacci, A. G.; Rodriguez, S.; Wei, X.;
Haddad, N.; Narayanan, B.; Ma, S.; Grinberg, N.; Yee, N. K.;
Krishnamurthy, D.; Senanayake, C. H., Novel, Tunable, and
Efficient Chiral Bisdihydrobenzooxaphosphole Ligands for
Asymmetric Hydrogenation. Org. Lett. 2010, 12, 176–179.
12) (a) Juge, S.; Genet, J. P., Asymmetric synthesis of
phosphinates, phosphine oxides and phosphines by Michaelis
Arbuzov rearrangement of chiral oxazaphospholidine.
Tetrahedron Lett. 1989, 30, 2783–2786. (b) Juge, S.; Stephan,
M.; Laffitte, J. A.; Genet, J. P., Efficient asymmetric synthesis of
optically pure tertiary mono and diphosphine ligands.
Tetrahedron Lett. 1990, 31, 6357–6360.
13) Corey, E. J.; Chen, Z.; Tanoury, G. J., A new and highly
enantioselective synthetic route to P-chiral phosphines and
diphosphines. J. Am. Chem. Soc. 1993, 115, 11000–11001.
14) Han, Z. S.; Goyal, N.; Herbage, M. A.; Sieber, J. D.; Qu, B.;
Xu, Y.; Li, Z.; Reeves, J. T.; Desrosiers, J.-N.; Ma, S.; Grinberg,
N.; Lee, H.; Mangunuru, H. P. R.; Zhang, Y.; Krishnamurthy, D.;
Lu, B. Z.; Song, J. J.; Wang, G.; Senanayake, C. H., Efficient
Asymmetric Synthesis of P-Chiral Phosphine Oxides via Properly
Designed and Activated Benzoxazaphosphinine-2-oxide Agents.
J. Am. Chem. Soc. 2013, 135, 2474–2477.
15) Sieber, J. D.; Chennamadhavuni, D.; Fandrick, K. R.; Qu, B.;
Han, Z. S.; Savoie, J.; Ma, S.; Samankumara, L. P.; Grinberg, N.;
Lee, H.; Song, J. J.; Senanayake, C. H., Development of New P-
Chiral P,π-Dihydrobenzooxaphosphole Hybrid Ligands for
Asymmetric Catalysis. Org. Lett. 2014, 16, 5494–5497.
16) Harmat, N. J. S.; Warren, S., Chiral synthesis of Z-2-
butylidenecyclohexan-1-ol and -1-yl phenylsulphide from
optically active phosphine oxides. Tetrahedron Lett. 1990, 31,
2743–2746.
REFERENCES
1) Meisenheimer, J; Lichtenstadt, L., Ber. dtsch. chem. Ges 1911,
44, 356–359.
2) (a) Bohr, H. G.; Shim, I.; Stein, C.; Ørum, H.; Hansen, H. F.;
Koch, T., Electronic Structures of LNA Phosphorothioate
Oligonucleotides. Mol. Ther. Nucleic Acids 2017, 8, 428–441.
(b) Iwamoto, N.; Butler, D. C. D.; Svrzikapa, N.; Mohapatra, S.;
Zlatev, I.; Sah, D. W. Y.; Meena; Standley, S. M.; Lu, G.; Apponi,
L. H.; Frank-Kamenetsky, M.; Zhang, J. J.; Vargeese, C.;
Verdine, G. L., Control of phosphorothioate stereochemistry
substantially increases the efficacy of antisense oligonucleotides.
Nat. Biotechnol. 2017, 35, 845–851.
3) Knouse, K. W.; deGruyter, J. N.; Schmidt, M. A.; Zheng, B.;
Vantourout, J. C.; Kingston, C.; Mercer, S. E.; McDonald, I. M.;
Olson, R. E.; Zhu, Y.; Hang, C.; Zhu, J.; Yuan, C.; Wang, Q.; Park,
P.; Eastgate, M. D.; Baran, P. S., Unlocking P(V): Reagents for
chiral phosphorothioate synthesis. Science 2018, 361, 1234–
1238.
4) (a) Pritchard, C. E.; Grasby, J. A.; Hamy, F.; Zacharek, A. M.;
Singh, M.; Karn, J.; Gait, M. J., Methylphosphonate mapping of
phosphate contacts critical for RNA recognition by the human
immunodeficiency virus tat and rev proteins. Nucleic Acids Res.
1994, 22, 2592–2600. (b) Koch, M.; Flür, S.; Kreutz, C.; Ennifar,
E.; Micura, R.; Polacek, N., Role of a ribosomal RNA phosphate
oxygen during the EF-G–triggered GTP hydrolysis. Proc. Natl.
Acad. Sci. 2015, 112, E2561. (c) Hamma, T.; Miller, P. S.,
Interactions of Hairpin Oligo-2′-O-Methylribonucleotides
Containing Methylphosphonate Linkages with HIV TAR RNA.
Antisense and Nucleic Acid Drug Dev. 2003, 13, 19–30.
5) (a) Agrawal, S.; Goodchild, J., Oligodeoxynucleoside
methylphosphonates: synthesis and enzymic degradation.
Tetrahedron Lett. 1987, 28, 3539–3542. (b) Reynolds, M. A.;
Hogrefe, R. I.; Jaeger, J. A.; Schwartz, D. A.; Riley, T. A.; Marvin,
W. B.; Daily, W. J.; Vaghefi, M. M.; Beck, T. A.; Knowles, S. K.;
Klem, R. E.; Arnold, L. J., Jr., Synthesis and Thermodynamics of
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Oligonucleotides
Methylphosphonate Linkages. Nucleic Acids Res. 1996, 24,
4584–4591.
Containing
Chirally
Pure
R
P
17) For examples, see (a) Yuen, O. Y.; Leung, M. P.; So, C. M.;
Sun, R. W.-Y.; Kwong, F. Y., Palladium-Catalyzed Direct
Arylation of Polyfluoroarenes for Accessing Tetra-ortho-
6) Miller, P. S., Oligonucleoside Methylphosphonates as
Antisense Reagents. Bio/Technology 1991, 9, 358–362.
7) For precedents of non-stereoselective MPO syntheses, see (a)
Miller, P. S.; Yano, J.; Yano, E.; Carroll, C.; Jayaraman, K.; Ts'o,
P. O. P., Nonionic nucleic acid analogs. Synthesis and
characterization of dideoxyribonucleoside methylphosphonates.
Biochemistry 1979, 18, 5134–5143. (b) Engels, J.; Jäger, A., Eine
neue Synthese von Nukleosidmethylphosphonaten. Angew.
Chem. Int. Ed. Eng. 1982, 21, 201–2015. (c) Lebedev, A. V.;
Wenzinger, G. R.; Wickstrom, E., A new DMAP-catalyzed
phosphonamidite coupling reaction for synthesis of
oligonucleotide methylphosphonate derivatives. Tetrahedron
Substituted
Biaryls:
Buchwald-type
Ligand
Having
Complementary −PPh2 Moiety Exhibits Better Efficiency. J.
Org. Chem. 2018, 83, 9008–9017. (b) Pedroni, J.; Boghi, M.;
Saget, T.; Cramer, N., Access to β-Lactams by Enantioselective
Palladium (0)-Catalyzed C (sp3)-H Alkylation. Angew. Chem.
Int. Ed. 2014, 53, 9064–9067.
18) (a) von Matt, P.; Pfaltz, A., Chiral phosphino-
aryldihydrooxazoles as ligands in asymmetric catalysis: Pd-
catalyzed allylic substitution. Angew. Chem. Int. Ed. Engl. 1993,
32, 566–568. (b) Sprinz, J.; Helmchen, G., Phosphinoaryl- and
phosphinoalkyloxazolines as new chiral ligands for
enantioselective catalysis: Very high enantioselectivity in
palladium catalyzed allylic substitutions. Tetrahedron Lett.
1993, 34, 1769–1772.
Lett. 1990, 31, 851–854. (d) Heliński, J.; Da
Michalski, J., N,N-diisopropyl-O-P-nitrophenyl-P-
̧bkowski, W.;
methylphosphonoamidite: novel difunctional PIII reagent in
oligonucleoside methylphosphonate synthesis containing 4-
nitrophenoxy group. Tetrahedron Lett. 1991, 32, 4981–4984.
8) For stereoselective MPO syntheses with moderate d.r., see (a)
Schell, P.; Engels, J. W., Rp-Diastereoselective synthesis of
dinucleoside methylphosphonates by the phosphoramidite
approach. Tetrahedron Lett. 1998, 39, 8629–8632. (b)
Rosmanitz, P.; Eisenhardt, S.; Bats, J. W.; Engels, J. W., New
proline derived chiral building blocks for nucleoside
methylphosphonate synthesis. Tetrahedron 1994, 50, 5719–
5734.
19) (a) Chan, J.; Jamison, T. F., Enantioselective Synthesis of
(−)-Terpestacin and Structural Revision of Siccanol Using
Catalytic
Stereoselective
Fragment
Couplings
and
Macrocyclizations. J. Am. Chem. Soc. 2004, 126, 10682–10691.
(b) Colby, E. A.; Jamison, T. F., P-Chiral, Monodentate
Ferrocenyl Phosphines, Novel Ligands for Asymmetric Catalysis.
J. Org. Chem. 2003, 68, 156–166.
20) (a) Naumann, K.; Zon, G.; Mislow, K., Use of hexa-
chlorodisilane as a reducing agent. Stereospecific deoxygenation
of acyclic phosphine oxides. J. Am. Chem. Soc. 1969, 91, 7012–
8
ACS Paragon Plus Environment